Canadian regulators approve Covidien's imaging agent

07/6/2009 | American City Business Journals

Health Canada has approved Covidien's abbreviated new drug submission for its kit used in preparing Technetium Tc 99m Sestamibi Injection, a generic version of Dupont's Cardiolite. With the approval, Covidien said it could have the myocardial perfusion imaging agent on the Canadian market this summer.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD